CUMBERLAND PHARMACEUTICALS INC (CPIX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q1 '10: 10.1M Q2 '10: 10.7M Q3 '10: 12.2M Q4 '10: 12.8M Q1 '11: 10.7M Q2 '11: 14.4M Q3 '11: 13.1M Q4 '11: 13M Q1 '12: 10.3M Q2 '12: 12.4M Q3 '12: 12.5M Q4 '12: 13.7M Q1 '13: 10.3M Q2 '13: 7.1M Q3 '13: 6.5M Q4 '13: 8.2M Q1 '14: 8.1M Q2 '14: 9.8M Q3 '14: 9.7M Q4 '14: 9.3M Q1 '15: 8.7M Q2 '15: 8.9M Q3 '15: 7.9M Q4 '15: 8M Q1 '16: 7.7M Q2 '16: 7.4M Q3 '16: 8.8M Q4 '16: 9.1M Q1 '17: 9.6M Q2 '17: 8.7M Q3 '17: 11.2M Q4 '17: 10.9M Q1 '18: 8.6M Q2 '18: 10.2M Q3 '18: 8.5M Q4 '18: 1.6M Q1 '19: 8.7M Q2 '19: 9.4M Q3 '19: 6.9M Q4 '19: 7.3M Q1 '20: 8.3M Q2 '20: 9.6M Q3 '20: 9.3M Q4 '20: 8.7M Q1 '21: 10.5M Q2 '21: 9.1M Q3 '21: 8.1M Q4 '21: 7.4M Q1 '22: 11.2M Q2 '22: 10.3M Q3 '22: 11.4M Q4 '22: 9.1M Q1 '23: 9.2M Q2 '23: 10.9M Q3 '23: 10.1M Q4 '23: 9.4M Q1 '24: 8.5M Q2 '24: 9.8M Q3 '24: 9.1M Q4 '24: 10.4M Q1 '25: 11.7M Q2 '25: 10.8M Q3 '25: 8.3M Q4 '25: 13.7M Q1 '26: 9.1M Q2 '26: 8.8M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 4M 8M 12M Q3 '17: 9M Q4 '17: 8.7M Q1 '18: 7.1M Q2 '18: 8.6M Q3 '18: 7M Q4 '18: 55K Q1 '19: 7.1M Q2 '19: 7.6M Q3 '19: 5.4M Q4 '19: 4.9M Q1 '20: 6.7M Q2 '20: 7M Q3 '20: 7.1M Q4 '20: 6.4M Q1 '21: 8.1M Q2 '21: 7.3M Q3 '21: 6.7M Q4 '21: 4.1M Q1 '22: 9M Q2 '22: 8.3M Q3 '22: 9.2M Q4 '22: 6.5M Q1 '23: 8M Q2 '23: 9.4M Q3 '23: 8.3M Q4 '23: 7.8M Q1 '24: 6.9M Q2 '24: 8.1M Q3 '24: 7.8M Q4 '24: 8.5M Q1 '25: 10.3M Q2 '25: 8.8M Q3 '25: 7.3M Q4 '25: 11.4M Q1 '26: 7.2M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '10: 810.5K Q2 '10: 1M Q3 '10: 2.4M Q4 '10: 2.2M Q1 '11: 1.4M Q2 '11: 3.6M Q3 '11: 3.1M Q4 '11: 1.7M Q1 '12: 646K Q2 '12: 1.9M Q3 '12: 3M Q4 '12: 3.3M Q1 '13: 1.3M Q2 '13: -1.1M Q3 '13: -1.5M Q4 '13: -2.5M Q1 '14: 408.1K Q2 '14: 1.2M Q3 '14: 989K Q4 '14: 946.1K Q1 '15: 4.1K Q2 '15: 673.9K Q3 '15: 270.9K Q4 '15: 162.7K Q1 '16: -500.6K Q2 '16: -105.3K Q3 '16: 130.1K Q4 '16: -957.4K Q1 '17: -657.8K Q2 '17: -1.7M Q3 '17: -839.3K Q4 '17: -903.3K Q1 '18: -2.5M Q2 '18: -869K Q3 '18: -1.8M Q4 '18: -3.3M Q1 '19: -1.3M Q2 '19: -1.4M Q3 '19: -3.2M Q4 '19: -3.4M Q1 '20: -1.8M Q2 '20: -1.6M Q3 '20: -1.2M Q4 '20: -1.7M Q1 '21: -324.3K Q2 '21: -1.4M Q3 '21: -1.6M Q4 '21: -4.4M Q1 '22: -1.3M Q2 '22: -1.8M Q3 '22: -288.6K Q4 '22: -2.3M Q1 '23: -1.5M Q2 '23: 22.9K Q3 '23: -1.9M Q4 '23: -6.2M Q1 '24: -1.9M Q2 '24: -1M Q3 '24: -1.7M Q4 '24: -1.8M Q1 '25: 1.3M Q2 '25: -3.1M Q3 '25: -2M Q4 '25: -1.4M Q1 '26: -3.1M Q2 '26: -3.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '10: 323.6K Q2 '10: 287.3K Q3 '10: 1M Q4 '10: 837.6K Q1 '11: 721.2K Q2 '11: 2.2M Q3 '11: 1.8M Q4 '11: 911.7K Q1 '12: 423.2K Q2 '12: 1.7M Q3 '12: 1.9M Q4 '12: 1.8M Q1 '13: 854.7K Q2 '13: -639K Q3 '13: -819.9K Q4 '13: -1.5M Q1 '14: 286.3K Q2 '14: 722.6K Q3 '14: 745.9K Q4 '14: 668.9K Q1 '15: 46.3K Q2 '15: 406K Q3 '15: 126.6K Q4 '15: 151.1K Q1 '16: -253.1K Q2 '16: -48K Q3 '16: 106.2K Q4 '16: -749.7K Q1 '17: -1.3M Q2 '17: -5.2M Q3 '17: -743K Q4 '17: -800.5K Q1 '18: -2.4M Q2 '18: -720.7K Q3 '18: -1.6M Q4 '18: -2.2M Q1 '19: -73.9K Q2 '19: -549.5K Q3 '19: -2M Q4 '19: -960.7K Q1 '20: -1.1M Q2 '20: -918.3K Q3 '20: -481.7K Q4 '20: -883.8K Q1 '21: 166.8K Q2 '21: 1.2M Q3 '21: -1.1M Q4 '21: -3.8M Q1 '22: -1.4M Q2 '22: -1.3M Q3 '22: -408.6K Q4 '22: -2.4M Q1 '23: 192.2K Q2 '23: 872.2K Q3 '23: -1M Q4 '23: -6.3M Q1 '24: -1.9M Q2 '24: -1.1M Q3 '24: -1.5M Q4 '24: -1.9M Q1 '25: 1.3M Q2 '25: -740.7K Q3 '25: -1.9M Q4 '25: -1.4M Q1 '26: -3.3M Q2 '26: -4.3M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '17: 2.2M Q4 '17: 2.2M Q1 '18: 1.5M Q2 '18: 1.5M Q3 '18: 1.5M Q4 '18: 1.5M Q1 '19: 1.7M Q2 '19: 1.8M Q3 '19: 1.6M Q4 '19: 2.4M Q1 '20: 1.6M Q2 '20: 2.6M Q3 '20: 2.1M Q4 '20: 2.3M Q1 '21: 2.4M Q2 '21: 1.7M Q3 '21: 1.3M Q4 '21: 3.3M Q1 '22: 2.2M Q2 '22: 2M Q3 '22: 2.2M Q4 '22: 2.7M Q1 '23: 1.3M Q2 '23: 1.5M Q3 '23: 1.8M Q4 '23: 1.5M Q1 '24: 1.6M Q2 '24: 1.7M Q3 '24: 1.3M Q4 '24: 2M Q1 '25: 1.4M Q2 '25: 2M Q3 '25: 988.8K Q4 '25: 2.2M Q1 '26: 1.9M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26

Operating Cash Flow Quarterly

-4M -2M 0 2M 4M 6M Q3 '10: 277.9K Q1 '11: 984K Q2 '11: 4M Q3 '11: 2.8M Q4 '11: 1M Q1 '12: 2.6M Q2 '12: 634.8K Q3 '12: 1.9M Q4 '12: 2M Q1 '13: 1.7M Q2 '13: 121.7K Q3 '13: -853.6K Q4 '13: -192.6K Q1 '14: 982.6K Q2 '14: 835.8K Q3 '14: 2.1M Q4 '14: 2.7M Q1 '15: 2M Q2 '15: 2M Q3 '15: 485.6K Q4 '15: 1.3M Q1 '16: 598.5K Q2 '16: -1.1M Q3 '16: 293.6K Q4 '16: 819.8K Q1 '17: 1.4M Q2 '17: -2.5M Q3 '17: 992.8K Q4 '17: -459.6K Q1 '18: 235.6K Q2 '18: 794.1K Q3 '18: -1.6M Q4 '18: 3.7M Q1 '19: -385.7K Q2 '19: 1.9M Q3 '19: 734.4K Q4 '19: 857K Q1 '20: 888.5K Q2 '20: 2.8M Q3 '20: 857.1K Q4 '20: 853.9K Q1 '21: 1.8M Q2 '21: 2.7M Q3 '21: -102K Q4 '21: 2M Q1 '22: -150.5K Q2 '22: 2.3M Q3 '22: 2.6M Q4 '22: 3.6M Q1 '23: -1.4M Q2 '23: 5.2M Q3 '23: 1.2M Q4 '23: 1M Q1 '24: -2.1M Q2 '24: -855.7K Q3 '24: 475.5K Q4 '24: 1.9M Q1 '25: 3.9M Q2 '25: 843.8K Q3 '25: 187.2K Q4 '25: 3K Q1 '26: 387K Q2 '26: 168.7K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-4M -2M 0 2M 4M 6M Q3 '10: 92.9K Q1 '11: 949.7K Q2 '11: 3.9M Q3 '11: 2.6M Q4 '11: 1M Q1 '12: 2.6M Q2 '12: 488.7K Q3 '12: 1.8M Q4 '12: 1.8M Q1 '13: 1.6M Q2 '13: 113.5K Q3 '13: -876.9K Q4 '13: -197.6K Q1 '14: 952.8K Q2 '14: 817.3K Q3 '14: 2M Q4 '14: 2.7M Q1 '15: 1.9M Q2 '15: 2M Q3 '15: 451.2K Q4 '15: 1.3M Q1 '16: 525.4K Q2 '16: -1.1M Q3 '16: 265.8K Q4 '16: 787.2K Q1 '17: 1.3M Q2 '17: -2.5M Q3 '17: 963.1K Q4 '17: -562.6K Q1 '18: 140.7K Q2 '18: 757.3K Q3 '18: -1.7M Q4 '18: 3.4M Q1 '19: -413.2K Q2 '19: 1.8M Q3 '19: 657.1K Q4 '19: 777.2K Q1 '20: 865.8K Q2 '20: 2.8M Q3 '20: 812.8K Q4 '20: 808.3K Q1 '21: 1.8M Q2 '21: 2.7M Q3 '21: -162K Q4 '21: 2M Q1 '22: -177.5K Q2 '22: 2.2M Q3 '22: 2.5M Q1 '23: -1.5M Q2 '23: 5.2M Q3 '23: 1.2M Q4 '23: 991.4K Q1 '24: -2.2M Q2 '24: -862.8K Q3 '24: 460.1K Q4 '24: 1.9M Q1 '25: 3.9M Q2 '25: 817.3K Q3 '25: 163.4K Q4 '25: 3K Q1 '26: 387K Q2 '26: 130.5K Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 8M 16M 24M Q2 '10: 21.2M Q3 '10: 20.8M Q1 '11: 20.8M Q2 '11: 20.7M Q3 '11: 20.5M Q1 '12: 20.2M Q2 '12: 20M Q3 '12: 19.7M Q1 '13: 18.9M Q2 '13: 18.4M Q3 '13: 18.2M Q1 '14: 18.2M Q2 '14: 18M Q3 '14: 17.8M Q1 '15: 17.4M Q2 '15: 17.2M Q3 '15: 17M Q1 '16: 16.3M Q2 '16: 16.2M Q3 '16: 16.5M Q1 '17: 16M Q2 '17: 16M Q3 '17: 15.9M Q1 '18: 15.7M Q2 '18: 15.7M Q3 '18: 15.6M Q1 '19: 15.9M Q2 '19: 15.5M Q3 '19: 15.4M Q1 '20: 15.6M Q2 '20: 15.2M Q3 '20: 15.1M Q1 '21: 15.2M Q2 '21: 15.1M Q3 '21: 14.9M Q1 '22: 14.7M Q2 '22: 14.7M Q3 '22: 14.5M Q1 '23: 14.6M Q2 '23: 14.6M Q3 '23: 14.3M Q1 '24: 14.1M Q2 '24: 14.1M Q3 '24: 14.1M Q1 '25: 15.3M Q2 '25: 15M Q3 '25: 15M Q1 '26: 15M Q2 '26: 15M Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.90 -0.60 -0.30 0.00 0.30 0.60 0.90 Q4 '10: 0.12 Q1 '11: 0.13 Q2 '11: 0.23 Q3 '11: 0.27 Q4 '11: 0.27 Q1 '12: 0.26 Q2 '12: 0.24 Q3 '12: 0.25 Q4 '12: 0.30 Q1 '13: 0.33 Q2 '13: 0.21 Q3 '13: 0.07 Q4 '13: -0.10 Q1 '14: -0.13 Q2 '14: -0.06 Q3 '14: 0.02 Q4 '14: 0.14 Q1 '15: 0.12 Q2 '15: 0.10 Q3 '15: 0.07 Q4 '15: 0.04 Q1 '16: 0.02 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: -0.06 Q1 '17: -0.12 Q2 '17: -0.44 Q3 '17: -0.50 Q4 '17: -0.50 Q1 '18: -0.57 Q2 '18: -0.30 Q3 '18: -0.36 Q4 '18: -0.45 Q1 '19: -0.30 Q2 '19: -0.29 Q3 '19: -0.31 Q4 '19: -0.23 Q1 '20: -0.30 Q2 '20: -0.32 Q3 '20: -0.22 Q4 '20: -0.22 Q1 '21: -0.14 Q2 '21: 0.00 Q3 '21: -0.04 Q4 '21: -0.24 Q1 '22: -0.34 Q2 '22: -0.51 Q3 '22: -0.47 Q4 '22: -0.38 Q1 '23: -0.28 Q2 '23: -0.13 Q3 '23: -0.17 Q4 '23: -0.44 Q1 '24: -0.59 Q2 '24: -0.73 Q3 '24: -0.77 Q4 '24: -0.47 Q1 '25: -0.25 Q2 '25: -0.22 Q3 '25: -0.24 Q4 '25: -0.19 Q1 '26: -0.49 Q2 '26: -0.73 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.